Bicalutamide-impurities | Pharmaffiliates

bicalutamide

Bicalutamide was patented in 1982 and approved for medical use in 1995. It is sold under the brand name Casodex among others, is an antiandrogen medication that is primarily used to treat prostate cancer.. Reference standards of Bicalutamide API, and its pharmacopeial, non pharmacopeial impurities, and stable isotopes are listed below

stdClass Object
(
    [pname] => Bicalutamide for system suitability (Y0001448)
    [catalogue_number] => PA EPY0001448
    [category_ids] => ,150,
    [chemical_name] => 
    [weight] => NA
    [form] => NA
    [cas] => NA
    [pslug] => bicalutamide-for-system-suitability-y0001448-paepy0001448
    [latest_product] => 0
    [linkproducts] => 0
    [offers_id] => 
    [offers_name] => 
    [offers_status] => 
    [offers_start_date] => 
    [offers_end_date] => 
    [pageview] => 
    [offers_slug] => 
    [offers_product_id] => 
    [offers_product_code] => 
    [offers_master_id] => 
    [offer_percentage] => 
    [offers_product_main_cat] => 
)
PA EPY0001448

Bicalutamide for system suitability (Y0001448)


  • Catalogue No.:PA EPY0001448

  • CAS :

    NA

  • Molecular Formula : NA

  • Molecular Weight : NA

stdClass Object
(
    [pname] => Bicalutamide (Y0001444)
    [catalogue_number] => PA EPY0001444
    [category_ids] => ,150,
    [chemical_name] => 
    [weight] => NA
    [form] => NA
    [cas] => NA
    [pslug] => bicalutamide-y0001444-paepy0001444
    [latest_product] => 0
    [linkproducts] => 0
    [offers_id] => 
    [offers_name] => 
    [offers_status] => 
    [offers_start_date] => 
    [offers_end_date] => 
    [pageview] => 
    [offers_slug] => 
    [offers_product_id] => 
    [offers_product_code] => 
    [offers_master_id] => 
    [offer_percentage] => 
    [offers_product_main_cat] => 
)
PA EPY0001444

Bicalutamide (Y0001444)


  • Catalogue No.:PA EPY0001444

  • CAS :

    NA

  • Molecular Formula : NA

  • Molecular Weight : NA